Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jayashree Kalpathy-Cramer

Concepts (405)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Retinopathy of Prematurity
35
2026
161
6.350
 Why?
Artificial Intelligence
38
2025
342
5.380
 Why?
Image Processing, Computer-Assisted
24
2026
768
4.520
 Why?
Glioblastoma
16
2024
344
3.230
 Why?
Brain Neoplasms
24
2024
1282
3.180
 Why?
Machine Learning
23
2026
555
2.900
 Why?
Algorithms
38
2024
1764
2.420
 Why?
Uterine Cervical Neoplasms
8
2025
268
2.410
 Why?
Diagnostic Imaging
19
2024
329
2.180
 Why?
Radiology
10
2024
170
1.920
 Why?
Natural Language Processing
7
2023
103
1.860
 Why?
Magnetic Resonance Imaging
41
2024
3734
1.820
 Why?
Information Storage and Retrieval
8
2015
118
1.710
 Why?
Retina
7
2026
314
1.560
 Why?
Neuroimaging
7
2022
278
1.520
 Why?
Glioma
8
2022
418
1.420
 Why?
Cervix Uteri
3
2025
51
1.360
 Why?
Radiotherapy Planning, Computer-Assisted
5
2016
142
1.270
 Why?
Image Interpretation, Computer-Assisted
13
2025
274
1.210
 Why?
Papillomavirus Infections
5
2025
364
1.070
 Why?
Software
10
2024
675
1.060
 Why?
ROC Curve
16
2026
594
1.060
 Why?
Humans
163
2026
141284
1.040
 Why?
Colposcopy
2
2025
18
1.010
 Why?
Optic Disk
2
2025
52
0.980
 Why?
Optical Imaging
1
2026
64
0.920
 Why?
Glaucoma
2
2025
242
0.890
 Why?
Tomography, X-Ray Computed
15
2023
2765
0.880
 Why?
Fundus Oculi
6
2026
86
0.870
 Why?
Geographic Atrophy
1
2026
91
0.870
 Why?
Severity of Illness Index
9
2024
2904
0.860
 Why?
Telemedicine
7
2023
893
0.850
 Why?
Gestational Age
18
2026
952
0.850
 Why?
Tomography, Optical Coherence
2
2025
258
0.830
 Why?
Reproducibility of Results
28
2025
3345
0.820
 Why?
Infant, Newborn
35
2026
6270
0.820
 Why?
Solitary Pulmonary Nodule
3
2021
21
0.780
 Why?
Radiology Information Systems
4
2022
33
0.780
 Why?
Privacy
1
2023
39
0.780
 Why?
Breast Neoplasms
7
2024
2246
0.770
 Why?
Ophthalmology
5
2023
106
0.770
 Why?
Diagnostic Techniques, Ophthalmological
3
2018
50
0.750
 Why?
Ophthalmoscopy
8
2024
38
0.710
 Why?
Radiologists
4
2024
51
0.710
 Why?
Bronchopulmonary Dysplasia
1
2026
402
0.670
 Why?
Sensitivity and Specificity
14
2024
1973
0.660
 Why?
Crowdsourcing
1
2020
18
0.650
 Why?
Medicine
1
2021
125
0.630
 Why?
Retinal Vessels
6
2024
75
0.620
 Why?
Breast Density
3
2024
7
0.610
 Why?
Retrospective Studies
27
2026
16447
0.610
 Why?
Mammography
4
2024
157
0.590
 Why?
Stroke
3
2023
1199
0.560
 Why?
Retinal Vein
4
2021
13
0.550
 Why?
Isocitrate Dehydrogenase
1
2017
68
0.530
 Why?
Female
59
2026
75814
0.520
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2016
108
0.490
 Why?
Lung Neoplasms
5
2021
2554
0.490
 Why?
Tumor Burden
4
2023
314
0.480
 Why?
Phenylurea Compounds
1
2016
100
0.480
 Why?
Databases, Factual
8
2021
1449
0.470
 Why?
Quinolines
1
2016
169
0.460
 Why?
Chemoradiotherapy
7
2023
232
0.460
 Why?
Gallbladder Neoplasms
3
2011
20
0.460
 Why?
Peripheral Arterial Disease
4
2023
491
0.460
 Why?
Radiography, Thoracic
5
2022
179
0.450
 Why?
Pattern Recognition, Automated
5
2023
74
0.450
 Why?
Prostatic Neoplasms
5
2024
1050
0.450
 Why?
Benchmarking
6
2024
179
0.440
 Why?
Neonatal Screening
5
2026
172
0.440
 Why?
Infant, Premature
10
2026
599
0.440
 Why?
Uterine Cervical Dysplasia
2
2025
30
0.440
 Why?
Delivery of Health Care
1
2021
948
0.430
 Why?
Hypertension, Pulmonary
1
2026
1939
0.430
 Why?
Subtraction Technique
1
2014
25
0.430
 Why?
Male
53
2026
70140
0.420
 Why?
Early Detection of Cancer
5
2025
432
0.420
 Why?
Neoplasm Recurrence, Local
2
2019
1075
0.420
 Why?
Radiation Oncology
2
2014
86
0.420
 Why?
Retinal Artery
3
2021
17
0.420
 Why?
Photography
6
2021
114
0.420
 Why?
Vocabulary, Controlled
1
2014
47
0.410
 Why?
White Matter
3
2023
146
0.410
 Why?
Phantoms, Imaging
7
2023
150
0.400
 Why?
Multimodal Imaging
1
2014
119
0.390
 Why?
Datasets as Topic
5
2021
124
0.380
 Why?
Middle Aged
32
2025
34658
0.370
 Why?
Aged
30
2025
24836
0.370
 Why?
Survival Analysis
4
2016
1322
0.360
 Why?
Cerebral Blood Volume
3
2020
5
0.350
 Why?
Contrast Media
9
2020
476
0.350
 Why?
Radiotherapy, Conformal
1
2011
73
0.350
 Why?
Internet
2
2014
683
0.350
 Why?
Mass Screening
4
2025
1309
0.340
 Why?
Adrenoleukodystrophy
2
2023
9
0.340
 Why?
Clinical Competence
2
2016
1210
0.330
 Why?
Proportional Hazards Models
4
2011
1268
0.330
 Why?
Brain
8
2021
2857
0.320
 Why?
Radiographic Image Interpretation, Computer-Assisted
2
2023
119
0.320
 Why?
Precision Medicine
3
2024
435
0.310
 Why?
Medical Informatics
4
2020
99
0.310
 Why?
Head and Neck Neoplasms
5
2020
557
0.300
 Why?
Neoplasms
7
2024
2731
0.300
 Why?
Database Management Systems
1
2008
51
0.280
 Why?
User-Computer Interface
4
2015
163
0.280
 Why?
Radiotherapy, Adjuvant
1
2008
217
0.270
 Why?
Endovascular Procedures
2
2023
358
0.270
 Why?
Automation
5
2020
101
0.270
 Why?
Observer Variation
4
2024
356
0.260
 Why?
Infant
12
2026
9820
0.260
 Why?
Adult
27
2025
39319
0.260
 Why?
Lung
6
2022
4051
0.260
 Why?
Prognosis
9
2024
4080
0.260
 Why?
Radiography
5
2022
845
0.240
 Why?
Risk Factors
9
2026
10490
0.230
 Why?
Diffusion Magnetic Resonance Imaging
2
2018
155
0.230
 Why?
Endoscopy, Gastrointestinal
1
2007
231
0.230
 Why?
Antineoplastic Agents
1
2016
2162
0.230
 Why?
Predictive Value of Tests
5
2025
2069
0.230
 Why?
Uncertainty
1
2026
137
0.230
 Why?
Rectal Neoplasms
2
2021
152
0.230
 Why?
Oropharyngeal Neoplasms
2
2015
54
0.230
 Why?
Reference Standards
7
2021
180
0.220
 Why?
Neoplasm Grading
3
2024
311
0.210
 Why?
Adenocarcinoma in Situ
1
2023
1
0.210
 Why?
Forecasting
3
2019
383
0.210
 Why?
Statistics as Topic
2
2014
298
0.200
 Why?
Postoperative Care
2
2019
280
0.200
 Why?
Ranibizumab
1
2023
20
0.200
 Why?
Imaging, Three-Dimensional
4
2023
565
0.200
 Why?
Radiotherapy, Intensity-Modulated
4
2016
136
0.190
 Why?
Biomedical Research
3
2024
684
0.190
 Why?
Neovascularization, Pathologic
3
2024
295
0.190
 Why?
Diagnosis, Computer-Assisted
2
2021
91
0.190
 Why?
Long QT Syndrome
1
2023
69
0.190
 Why?
Myeloid-Derived Suppressor Cells
1
2023
72
0.190
 Why?
Documentation
2
2015
194
0.190
 Why?
Macular Degeneration
1
2024
186
0.190
 Why?
Oxygen
2
2021
986
0.190
 Why?
Quality Assurance, Health Care
2
2014
319
0.180
 Why?
Computer Communication Networks
2
2020
32
0.180
 Why?
Rheumatic Diseases
1
2022
93
0.180
 Why?
Diverticulitis
1
2021
8
0.180
 Why?
Patient-Specific Modeling
2
2024
43
0.170
 Why?
Biomarkers
4
2018
4180
0.170
 Why?
Cohort Studies
6
2022
5809
0.170
 Why?
Hospital Units
1
2021
32
0.170
 Why?
Musculoskeletal System
1
2021
49
0.170
 Why?
Racism
1
2023
141
0.170
 Why?
Intestinal Obstruction
1
2021
53
0.170
 Why?
India
1
2021
210
0.160
 Why?
Dacarbazine
3
2015
95
0.160
 Why?
Tibial Meniscus Injuries
1
2021
49
0.160
 Why?
Perfusion Imaging
1
2020
62
0.160
 Why?
Microcirculation
2
2017
137
0.160
 Why?
Radiometry
1
2020
54
0.160
 Why?
Health Information Exchange
1
2020
21
0.160
 Why?
Hyperemia
1
2020
48
0.160
 Why?
Biomarkers, Tumor
3
2016
1250
0.160
 Why?
Medical Records Systems, Computerized
2
2013
96
0.160
 Why?
Carcinoma, Squamous Cell
2
2015
641
0.160
 Why?
Brain Ischemia
1
2023
351
0.160
 Why?
Signal Processing, Computer-Assisted
2
2017
150
0.160
 Why?
Area Under Curve
4
2021
324
0.150
 Why?
Lung Injury
1
2022
221
0.150
 Why?
Brain Diseases
1
2021
150
0.150
 Why?
Cerebellar Neoplasms
1
2022
179
0.150
 Why?
Vascular Endothelial Growth Factor A
2
2023
547
0.150
 Why?
Low Back Pain
1
2021
109
0.150
 Why?
Positron Emission Tomography Computed Tomography
1
2020
112
0.150
 Why?
Hematopoietic Stem Cell Transplantation
2
2023
670
0.150
 Why?
Medulloblastoma
1
2022
218
0.150
 Why?
Appendicitis
1
2021
145
0.150
 Why?
Antineoplastic Agents, Alkylating
2
2018
70
0.150
 Why?
Aneurysm, Ruptured
1
2019
37
0.150
 Why?
Treatment Outcome
8
2023
11216
0.150
 Why?
Capillary Permeability
1
2019
133
0.150
 Why?
Age Determination by Skeleton
1
2018
15
0.150
 Why?
Blood-Brain Barrier
2
2017
146
0.150
 Why?
Drug Resistance, Neoplasm
1
2024
840
0.150
 Why?
Models, Biological
4
2024
1810
0.150
 Why?
Cone-Beam Computed Tomography
1
2018
31
0.140
 Why?
Colonic Neoplasms
1
2021
244
0.140
 Why?
Linear Models
1
2021
855
0.140
 Why?
Intracranial Aneurysm
1
2019
100
0.140
 Why?
Arteries
2
2019
260
0.140
 Why?
Ventricular Dysfunction, Right
1
2021
244
0.140
 Why?
Antibodies, Monoclonal, Humanized
1
2024
908
0.140
 Why?
Medical Record Linkage
1
2018
68
0.140
 Why?
Global Health
1
2021
384
0.130
 Why?
Prospective Studies
7
2023
7805
0.130
 Why?
Antineoplastic Combined Chemotherapy Protocols
2
2019
1791
0.130
 Why?
Gadolinium
1
2017
85
0.130
 Why?
Bayes Theorem
2
2016
414
0.130
 Why?
Polysaccharides, Bacterial
1
2017
67
0.130
 Why?
Diagnosis, Differential
3
2019
1491
0.130
 Why?
Respiratory Insufficiency
1
2021
325
0.130
 Why?
Preoperative Period
1
2017
143
0.130
 Why?
Gray Matter
1
2018
86
0.130
 Why?
Patient Readmission
1
2022
698
0.130
 Why?
North America
3
2024
304
0.130
 Why?
Computer Simulation
5
2024
1009
0.130
 Why?
Skin Diseases, Genetic
1
2016
13
0.120
 Why?
Chronic Pain
1
2021
281
0.120
 Why?
Pharyngeal Muscles
1
2016
6
0.120
 Why?
Blood Vessels
1
2017
173
0.120
 Why?
Nasopharyngeal Neoplasms
1
2016
20
0.120
 Why?
SEER Program
3
2011
219
0.120
 Why?
Angiogenesis Inhibitors
2
2016
229
0.120
 Why?
National Cancer Institute (U.S.)
3
2020
48
0.120
 Why?
Blood Volume Determination
1
2015
5
0.120
 Why?
Vascular Malformations
1
2016
50
0.120
 Why?
Risk Assessment
4
2025
3522
0.120
 Why?
Liver Cirrhosis
1
2017
283
0.120
 Why?
Acute Kidney Injury
1
2023
822
0.110
 Why?
Positron-Emission Tomography
4
2021
309
0.110
 Why?
Fibrosis
1
2017
541
0.110
 Why?
Cranial Irradiation
1
2015
84
0.110
 Why?
Physical Phenomena
1
2014
13
0.110
 Why?
Organs at Risk
1
2014
35
0.110
 Why?
Societies, Medical
3
2024
859
0.110
 Why?
Radiation Injuries
1
2016
148
0.110
 Why?
Birth Weight
3
2023
511
0.110
 Why?
Aged, 80 and over
5
2018
7948
0.110
 Why?
Longitudinal Studies
2
2019
2929
0.110
 Why?
Brachial Plexus
1
2014
34
0.110
 Why?
Tumor Microenvironment
1
2018
711
0.110
 Why?
Chemoradiotherapy, Adjuvant
2
2011
44
0.110
 Why?
Administration, Oral
1
2016
825
0.110
 Why?
Deglutition Disorders
1
2016
151
0.100
 Why?
Joint Instability
1
2016
171
0.100
 Why?
Mutation
3
2024
4006
0.100
 Why?
Computer-Assisted Instruction
1
2014
68
0.100
 Why?
Arteriovenous Malformations
1
2013
29
0.100
 Why?
Bias
3
2024
208
0.100
 Why?
Computer Literacy
1
2013
5
0.100
 Why?
Health Information Systems
1
2013
17
0.100
 Why?
Young Adult
7
2018
13727
0.090
 Why?
Survival Rate
3
2018
1979
0.090
 Why?
Terminology as Topic
1
2014
244
0.090
 Why?
Otorhinolaryngologic Neoplasms
1
2011
2
0.090
 Why?
Nomograms
1
2011
58
0.090
 Why?
Research Design
2
2014
1105
0.090
 Why?
Feasibility Studies
2
2014
1037
0.090
 Why?
Workload
1
2013
164
0.090
 Why?
Child
8
2024
22390
0.080
 Why?
Support Vector Machine
2
2021
38
0.080
 Why?
Muscle, Skeletal
1
2020
1747
0.080
 Why?
Emergency Service, Hospital
1
2021
2210
0.080
 Why?
Periodicals as Topic
1
2012
198
0.080
 Why?
Liver
1
2017
1821
0.080
 Why?
Papillomaviridae
2
2023
121
0.070
 Why?
Oregon
1
2008
78
0.070
 Why?
Exercise
1
2020
2113
0.070
 Why?
Total Quality Management
1
2008
59
0.070
 Why?
United States
5
2024
15298
0.070
 Why?
Lower Extremity
2
2023
437
0.070
 Why?
MEDLINE
1
2008
20
0.070
 Why?
Dilatation, Pathologic
2
2018
61
0.070
 Why?
Follow-Up Studies
3
2024
5222
0.070
 Why?
Breast
2
2019
155
0.070
 Why?
Protein Kinase Inhibitors
1
2013
918
0.070
 Why?
Electronic Health Records
1
2015
1129
0.060
 Why?
Monte Carlo Method
2
2017
150
0.060
 Why?
Cluster Analysis
1
2007
518
0.060
 Why?
Clinical Protocols
2
2019
273
0.060
 Why?
Tanzania
1
2025
57
0.060
 Why?
Vaginal Smears
1
2025
56
0.060
 Why?
Proof of Concept Study
1
2024
84
0.050
 Why?
Critical Illness
2
2021
852
0.050
 Why?
Netherlands
1
2024
86
0.050
 Why?
Intensive Care Units, Neonatal
2
2018
268
0.050
 Why?
Kinetics
2
2019
1620
0.050
 Why?
Physicians
1
2013
930
0.050
 Why?
Brain Infarction
1
2023
23
0.050
 Why?
Ethers, Cyclic
1
2023
11
0.050
 Why?
DNA, Viral
1
2025
363
0.050
 Why?
Troponin T
1
2023
63
0.050
 Why?
Benzofurans
1
2023
25
0.050
 Why?
Models, Theoretical
2
2021
582
0.050
 Why?
X-Rays
1
2022
31
0.050
 Why?
DNA Helicases
1
2024
142
0.050
 Why?
Data Curation
1
2022
19
0.050
 Why?
Adrenal Glands
1
2022
79
0.050
 Why?
Smartphone
1
2023
95
0.050
 Why?
Quinazolines
2
2013
260
0.050
 Why?
Logistic Models
2
2021
2098
0.050
 Why?
Cross-Sectional Studies
2
2024
5653
0.050
 Why?
Limb Salvage
1
2022
65
0.050
 Why?
Health Services
1
2022
116
0.050
 Why?
Vagina
1
2024
188
0.040
 Why?
Antineoplastic Agents, Immunological
1
2024
191
0.040
 Why?
Utilization Review
1
2021
41
0.040
 Why?
Edema
1
2022
127
0.040
 Why?
Receptors, GABA
1
2021
14
0.040
 Why?
Nepal
1
2021
31
0.040
 Why?
Neoadjuvant Therapy
1
2024
429
0.040
 Why?
Genetic Therapy
1
2023
315
0.040
 Why?
Case-Control Studies
2
2019
3577
0.040
 Why?
Massachusetts
1
2021
176
0.040
 Why?
Clinical Trials as Topic
2
2016
1035
0.040
 Why?
Early Diagnosis
1
2021
243
0.040
 Why?
Genotype
1
2025
1854
0.040
 Why?
Seizures
1
2024
441
0.040
 Why?
Abdomen
1
2021
138
0.040
 Why?
Incidence
2
2020
2809
0.040
 Why?
Internationality
1
2021
156
0.040
 Why?
Ankle
1
2020
61
0.040
 Why?
Indoles
2
2013
472
0.040
 Why?
Cell Cycle Proteins
1
2024
628
0.040
 Why?
Models, Statistical
2
2016
669
0.040
 Why?
Chemotherapy, Cancer, Regional Perfusion
1
2019
29
0.040
 Why?
Hematopoietic Stem Cells
1
2023
408
0.040
 Why?
Disease Progression
2
2020
2808
0.040
 Why?
Hand Bones
1
2018
3
0.040
 Why?
Infant, Low Birth Weight
1
2020
145
0.040
 Why?
Risk
1
2021
903
0.040
 Why?
Nuclear Proteins
1
2024
718
0.040
 Why?
Bevacizumab
1
2019
135
0.040
 Why?
Quality Control
1
2019
160
0.040
 Why?
Genomics
1
2024
811
0.040
 Why?
Arthroscopy
1
2021
245
0.040
 Why?
Reference Values
1
2020
803
0.040
 Why?
Radiation Exposure
1
2019
60
0.040
 Why?
Ventricular Function, Right
1
2021
284
0.040
 Why?
Hyperlipidemias
1
2019
126
0.040
 Why?
Medical Oncology
1
2021
316
0.040
 Why?
Hemizygote
1
2017
5
0.030
 Why?
Carbon Tetrachloride
1
2017
13
0.030
 Why?
Half-Life
1
2017
145
0.030
 Why?
Diabetic Retinopathy
1
2020
202
0.030
 Why?
Diffusion
1
2017
121
0.030
 Why?
Skull
1
2018
146
0.030
 Why?
Permeability
1
2017
163
0.030
 Why?
Chemotherapy, Adjuvant
1
2018
383
0.030
 Why?
Ecosystem
1
2022
574
0.030
 Why?
Asymptomatic Diseases
1
2017
98
0.030
 Why?
Outpatients
1
2021
425
0.030
 Why?
Tissue Distribution
1
2017
325
0.030
 Why?
Information Dissemination
1
2019
209
0.030
 Why?
Signal-To-Noise Ratio
1
2016
67
0.030
 Why?
Expert Systems
1
2016
4
0.030
 Why?
Prostate
1
2017
173
0.030
 Why?
Respiration, Artificial
1
2021
689
0.030
 Why?
Palate, Soft
1
2016
15
0.030
 Why?
Heart Ventricles
1
2021
748
0.030
 Why?
Transcription Factors
1
2024
1706
0.030
 Why?
Dose-Response Relationship, Radiation
1
2016
143
0.030
 Why?
Evaluation Studies as Topic
1
2016
172
0.030
 Why?
Video Recording
1
2017
197
0.030
 Why?
Antineoplastic Protocols
1
2015
6
0.030
 Why?
Platelet Count
1
2015
88
0.030
 Why?
Magnetic Resonance Angiography
1
2017
248
0.030
 Why?
Molecular Imaging
1
2016
55
0.030
 Why?
Perfusion
1
2016
226
0.030
 Why?
Radiotherapy Dosage
1
2016
280
0.030
 Why?
Motion
1
2015
99
0.030
 Why?
Cerebrovascular Circulation
1
2017
271
0.030
 Why?
Diffusion Tensor Imaging
1
2015
75
0.030
 Why?
Disease-Free Survival
1
2016
713
0.030
 Why?
Intensive Care Units
1
2021
868
0.030
 Why?
Randomized Controlled Trials as Topic
1
2021
1610
0.030
 Why?
Thoracic Neoplasms
1
2014
39
0.030
 Why?
Mass Spectrometry
1
2017
734
0.030
 Why?
Image Enhancement
1
2015
191
0.030
 Why?
Comorbidity
1
2019
1671
0.030
 Why?
Carcinoma
1
2016
230
0.030
 Why?
DNA Modification Methylases
1
2013
18
0.030
 Why?
DNA Repair Enzymes
1
2013
29
0.030
 Why?
Congresses as Topic
1
2015
223
0.020
 Why?
Argentina
1
2013
28
0.020
 Why?
Child, Preschool
2
2018
11511
0.020
 Why?
Pandemics
1
2021
1655
0.020
 Why?
Molecular Targeted Therapy
1
2016
420
0.020
 Why?
Statistics, Nonparametric
1
2013
432
0.020
 Why?
Fluorescein Angiography
1
2013
175
0.020
 Why?
Adolescent
3
2018
22116
0.020
 Why?
Smoking
1
2019
1576
0.020
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
226
0.020
 Why?
Life Tables
1
2011
20
0.020
 Why?
Effect Modifier, Epidemiologic
1
2011
9
0.020
 Why?
Hemodynamics
1
2016
1106
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2013
849
0.020
 Why?
Tumor Suppressor Proteins
1
2013
325
0.020
 Why?
Time Factors
1
2022
6951
0.020
 Why?
Hospitalization
1
2021
2264
0.020
 Why?
Pregnancy
1
2023
7035
0.020
 Why?
Educational Status
1
2013
463
0.020
 Why?
Polymerase Chain Reaction
1
2013
1050
0.020
 Why?
Hypertension
1
2019
1250
0.020
 Why?
Probability
1
2011
307
0.020
 Why?
Diabetes Mellitus
1
2019
1078
0.020
 Why?
Lymphatic Metastasis
1
2011
327
0.020
 Why?
Pilot Projects
1
2015
1820
0.020
 Why?
Rats
1
2017
5556
0.020
 Why?
Kaplan-Meier Estimate
1
2011
910
0.020
 Why?
PubMed
1
2008
11
0.020
 Why?
Ultrasonography
1
2012
765
0.020
 Why?
Disease Models, Animal
1
2017
4414
0.020
 Why?
Neoplasm Staging
1
2011
1397
0.020
 Why?
Attitude of Health Personnel
1
2013
1178
0.010
 Why?
Internship and Residency
1
2014
1230
0.010
 Why?
Age Factors
1
2011
3295
0.010
 Why?
Mice
1
2017
17969
0.010
 Why?
Animals
1
2017
37328
0.010
 Why?
Kalpathy-Cramer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (405) concept(s)
_
Co-Authors Expand Description
See all (15) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)